期刊文献+

癌胚抗原糖类抗原72-4和糖类抗原19-9对胃癌的诊断价值 被引量:11

Diagnostic value of CEA,CA72-4 and CA19-9 in gastric cancer
下载PDF
导出
摘要 目的探讨检测血清肿瘤标志物癌胚抗原(CEA)、糖类抗原72-4(CA72-4)和糖类抗原19-9(CA19-9)在胃癌诊断中的价值。方法应用化学发光和电化学发光技术检测经病理检查确诊为胃癌患者104例,胃良性疾病患者43例及健康对照组51例的血清CEA、CA72-4和CA19-9的水平。结果胃癌组患者CEA,CA72-4和CA19-9水平均高于胃良性疾病组和健康对照组(P<0.05),而胃良性疾病组和健康对照组3种肿瘤标志物水平差异无统计学意义(P>0.05)。ROC曲线分析显示,CEA、CA19-9、CA72-4曲线下面积分别为0.778、0.670、0.715。CEA取cut off值为4.7ng/mL时,灵敏度和特异度分别为51.2%和95.7%。CA19-9取cut off值为28U/mL时,灵敏度和特异度分别为43.0%和95.7%。CA72-4取cut off值为6.3U/mL时,灵敏度和特异度分别为29.1%和94.7%。若联合检测3种肿瘤标志物,灵敏度可提高到61.5%,特异度为84.7%。结论 CEA、CA72-4和CA19-9对胃癌有较好诊断价值;CEA是诊断胃癌最有价值的指标;3项指标联合检测可提高对胃癌诊断的敏感度。 Objective To discuss the diagnostic value of serum tumor markers carcinoma embryonic antigen(CEA),CA72-4 and CA19-9 in the patients with gastric cancer.Methods The serum levels of CEA,CA72-4and CA19-9 were measured by chemiluminescence immunoassay(CLIA) and electrochemiluminescence immunoassay(ECLIA) in 104 patients with gastric cancer,43 patients with benign gastric diseases and 51 healthy persons.Results Serum levels of four tumor markers in the patients with gastric cancer were higher than those in benign gastric disease group and healthy control group(P0.05).There was no significant difference between the benign gastric disease group and healthy control group(P0.05).The areas under the curve(AUC) of CEA,CA19-9 and CA72-4 were 0.778,0.670 and 0.715 respectively by application of ROC curve.The cut off value of CEA was 4.7 ng/mL,which resulted in 51.2% sensitivity and 95.7% specificity.The cut off value of CA19-9 was 28 U/mL,which resulted in 43.0% sensitivity and 95.7%specificity.The cut off value of CA72-4 was 6.3 U/mL,which resulted in 29.1% sensitivity and 94.7% specificity.Compared to single detection,the sensitivity detection of the three tumor markers were improved significantly.Conclusion CEA,CA19-9 and CA72-4 have the good diagnostic value to gastric cancer.CEA is the most effective tumor marker of gastric cancer.Combined detection of serum tumor markers CEA,CA72-4 and CA19-9 can improve the sensitivity of gastric cancer.
出处 《检验医学与临床》 CAS 2012年第1期20-21,23,共3页 Laboratory Medicine and Clinic
关键词 胃癌 癌胚抗原 糖类抗原19-9 糖类抗原72-4 gastric cancer carcinoma embryonic antigen CA19-9 CA72-4
  • 相关文献

参考文献10

二级参考文献45

共引文献805

同被引文献97

  • 1黄旻,李会灵,李国华.血清肿瘤标志物在胃癌诊治中的研究进展[J].中国医药导报,2006,3(9):35-36. 被引量:8
  • 2陶冀,游廉,王锡山.乳腺癌肿瘤标志物CEA、CA15-3表达水平的临床意义[J].中国肿瘤临床,2005,32(13):751-754. 被引量:21
  • 3蒋琳琳,杨中华.胃癌血清肿瘤标志物的临床评价[J].四川肿瘤防治,2006,19(3):200-201. 被引量:7
  • 4肖丽萍,毕向军,李亚南,陈晓清,张晓峰,余新沛,刘岗,杨明常,宋骤.前列腺特异性抗原对前列腺癌早期诊断的价值[J].南方医科大学学报,2007,27(1):107-108. 被引量:10
  • 5Rain A J,Chan D W.Cancer proteomics:Serum diagnostics for tumor marker discovery[J].Ann N Y Acad Sci,2004,1022:826.
  • 6Takahashi Y,Takeuchi T,Sakamoto,et al.The usefulness of CEA and/or CA199 in monitoring for recurrence in gastric cancer patients:a prospective clinical study[J].Gastric Cancer,2003,6(3):142.
  • 7Ubukata H, Katano M, Motohashi G, et al. Evaluation of CA72-4 as a tumor marker in patients with gastric cancer [J]. Cancer Res Clin Oncol, 2003,30( 11 ) : 1821-1824.
  • 8Ni XG, Bai XF, Mao YL, et al. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer [J]. EJSO,2005,31(2) : 164-169.
  • 9Ucar E, Semerci E, Ustun H, et al. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer[J]. Adv Ther, 2008,25 (10) : 1075-1084.
  • 10朱汉民,沈霞.临床实验诊断学[M].上海:上海科学技术出版卡t,2004:918-934.

引证文献11

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部